Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation

IRCCS Azienda Ospedaliero-Universitaria di Bologna100 enrolled

Overview

observational study through which we aim to collect information on metabolic compensation, the degree of satisfaction with hypoglycemic therapy, the onset of complications of diabetes or liver disease, evaluation of survival, in patients on the list for at least three months or already undergoing liver transplantation for at least three months

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Diabetes Mellitus Type 2 Liver Transplant

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * type 2 diabetes mellitus * presence on the list for OLT for at least 3 months or have already been submitted to OLT for at least 3 months * age ≥ 18 years * signature of written informed consent to participate in the observational study, either by the participant or legal guardian Exclusion Criteria: \- Pregnancy or breastfeeding

Locations (1)

Lucia Brodosi

Bologna, BO, Italy

Outcomes

Primary Outcomes

glycosilated hemoglobin (%)

glycometabolic control in relation to therapy

Time frame: through study completion, an average of 5 years

Secondary Outcomes

degree of satisfaction with therapy

degree of satisfaction with therapy through the administration of Diabetes Treatment Satisfaction Questionnaire (DTSQ)